Vital Therapies reported $232.31M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Enanta Pharmaceuticals ENTA:US $ 1.15B 259.62M
Epizyme EPZM:US $ 523.52M 323.9M
Insmed INSM:US $ 3.26B 35.6M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Omeros OMER:US $ 861.81M 63.14M
Orasure Technologies OSUR:US $ 814.42M 84.75M
Quidel QDEL:US $ 5.88B 424.85M
Regulus Therapeutics RGLS:US $ 60.11M 810.37K
Revance Therapeutics RVNC:US $ 2B 126.68M
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
United Therapeutics UTHR:US $ 8.29B 249.36M
Vital Therapies VTL:US $ 232.31M 34.34M
Xoma XOMA:US $ 279.95M 104.59M